DBSdeep brain stimulationCSAIParkinson’s diseasePDlevodopa–carbidopa intestinal gel
…equently initiated therapy (6873 patients; +58.9%), followed by DBS (1592 patients; −20.7%) and LCIG (364 patients; +152.9%). Most …
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: CSAI ×
CSAI
This treatment is selected. Its supporting articles are shown below.